While the timing and intensity of seasonal illness is always unpredictable, illnesses like cold, cough, and flu have been more volatile than ever since the emergence of COVID-19. This has made it difficult for cold, cough and flu relief brands to predict where and when consumers will need their products the most, resulting in out-of-stock products and potentially permanently-lost sales.
A leading cold, cough & flu relief brand addressed this problem with Kinsa Insights’ Retail Sell-In solution, which identifies geographies where illness-based sales demand is likely to surge 4 weeks ahead of time, and identified $69M in under-forecasted sales opportunities. Learn more in this case study.
